(Q34546840)

2 August 2017

1 reference

title

Chemotherapy-induced lung disease (English)

1 reference

2 August 2017

1 reference

Andrew H Limper

1

1 reference

2 August 2017

publication date

1 March 2004

1 reference

Clinics in Chest Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

25

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

53-64

1 reference

Drug-induced pulmonary disease: an update

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary toxicity of antineoplastic agents: Anaesthetic and postoperative implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

1 reference

7 January 2021

Bleomycin-induced pulmonary function abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Oxygen-Exacerbated Bleomycin Pulmonary Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Nodular bleomycin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Mitomycin-induced pulmonary toxicity: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Lung toxicity associated with cyclophosphamide use. Two distinct patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-1990. A 28-year-old man with increasing dyspnea, dry cough, and fever after chemotherapy for lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Gemcitabine-induced pulmonary toxicity: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Severe pulmonary toxicity in a patient treated with gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary Toxicity Associated with Bischloroethylnitrosourea (BCNU)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Etoposide-induced pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

PULMONARY COMPLICATIONS OF CANCER THERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary Infiltrates Following Administration of Paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: long-term follow-up of a phase I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Irinotecan-associated pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Interferon-induced sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Alterations in pulmonary function in cancer patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary edema as a complication of interleukin-2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Pulmonary toxicity of recombinant human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Clinical toxicity of cytokines used as haemopoietic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

Vinblastine-associated pulmonary toxicity in patients receiving combination therapy with mitomycin and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2803%2900123-0

7 January 2021

10.1016/S0272-5231(03)00123-0

Identifiers

DOI

1 reference

2 August 2017

1 reference